Sept. 3, 2004 — Daily treatment with anakinra is effective in controlling the clinical manifestations of ankylosing spondylitis (AS), with a 61% improvement in spinal and sacroiliac joint (SIJ) ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued an emergency use authorization for anakinra injection in the treatment of COVID-19 among ...

The FDA has issued an emergency use authorization (EUA) for anakinra (Kineret) injection for the treatment of COVID-19 in certain hospitalized adults. These patients include those with pneumonia who ...

Gout flare in the hand of an elderly person Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares. Undergoing 5 days of therapy with the IL-1 receptor ...

SAN FRANCISCO (MedscapeWire) Nov 16 — The drug anakinra relieved symptoms in a significant proportion of patients with erosive rheumatoid arthritis, according to findings of a study presented here ...

According to a study by Chevalier and colleagues, a single intra-articular injection of anakinra is no more effective than placebo for treating the symptoms of knee osteoarthritis (OA). This result, ...

Please provide your email address to receive an email when new articles are posted on . Interleukin-1 inhibition with the receptor antagonist anakinra did not significantly improve symptom severity in ...

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications.

The appraisal committee considered evidence submitted by Sobi, a review of this submission by the evidence review group (ERG), NICE's technical report and responses from stakeholders. See the ...

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications.